Cystic pancreatic lesions: can we diagnose them accurately what to look for? FNA marker molecular analysis resection, surveillance, or endoscopic treatment?
Brugge
W R
WR
GI Unit, Blake 452, Massachusetts General Hospital, Boston, MA 02114, USA. brugge.william@mgh.harvard.edu
D044963:Biopsy, Fine-Needle; D002760:Cholangiopancreatography, Endoscopic Retrograde; D003536:Cystadenocarcinoma / Q000175:diagnosis / Q000000981:diagnostic imaging; D018291:Cystadenoma, Mucinous / Q000000981:diagnostic imaging; D018293:Cystadenoma, Serous / Q000175:diagnosis / Q000000981:diagnostic imaging; D003937:Diagnosis, Differential; D016145:Endoscopy, Digestive System / Q000379:methods*; D019160:Endosonography; D006801:Humans; D010181:Pancreatic Cyst / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery; D012307:Risk Factors; D014057:Tomography, X-Ray Computed